-
Screening for triploidy by the risk algorithms for trisomies 21, 18 and 13 at 11 weeks to 13 weeks and 6 days of gestation.
Kagan KO, Anderson JM, Anwandter G, Nekrasova K, Nicolaides KH.
Prenat Diagn 2008;28:1209-13. -
Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free beta-hCG and pregnancy-associated plasma protein-A.
Kagan KO, Wright D, Valencia C, Maiz N, Nicolaides KH.
Hum Reprod 2008;23:1968-75. -
Value of prenatal magnetic resonance imaging in the prediction of postnatal outcome in fetuses with diaphragmatic hernia.
Jani J, Cannie M, Sonigo P, Robert Y, Moreno O, Benachi A, Vaast P, Gratacos E, Nicolaides KH, Deprest J.
Ultrasound Obstet Gynecol 2008;32:793-9. -
Timing of lung size assessment in the prediction of survival in fetuses with diaphragmatic hernia.
Jani J, Nicolaides KH, Benachi A, Moreno O, Favre R, Gratacos E, Deprest J.
Ultrasound Obstet Gynecol 2008;31:37-40. -
Prediction of outcome in isolated congenital diaphragmatic hernia and its consequences for fetal therapy.
Gucciardo L, Deprest J, Done' E, Van Mieghem T, Van de Velde M, Gratacos E, Jani J, Peralta F, Nicolaides K.
Best Pract Res Clin Obstet Gynaecol 2008;22:123-38. -
Prenatal diagnosis, prediction of outcome and in utero therapy of isolated congenital diaphragmatic hernia.
Doné E, Gucciardo L, Van Mieghem T, Jani J, Cannie M, Van Schoubroeck D, Devlieger R, Catte LD, Klaritsch P, Mayer S, Beck V, Debeer A, Gratacos E, Nicolaides K, Deprest J.
Prenat Diagn 2008;28:581-91. -
Maternal cardiac output between 11 and 13 weeks of gestation in the prediction of preeclampsia and small for gestational age.
De Paco C, Kametas N, Rencoret G, Strobl I, Nicolaides KH.
Obstet Gynecol 2008;111:292-300. -
Choroid plexus cyst, intracardiac echogenic focus, hyperechogenic bowel and hydronephrosis in screening for trisomy 21 at 11 + 0 to 13 + 6 weeks.
Dagklis T, Plasencia W, Maiz N, Duarte L, Nicolaides KH.
Ultrasound Obstet Gynecol 2008;31:132-5. -
Cardiac dysfunction and cell damage across clinical stages of severity in growth-restricted fetuses.
Crispi F, Hernandez-Andrade E, Pelsers MM, Plasencia W, Benavides-Serralde JA, Eixarch E, Le Noble F, Ahmed A, Glatz JF, Nicolaides KH, Gratacos E.
Am J Obstet Gynecol 2008;199:254.1-8. -
Cervical length and obstetric history predict spontaneous preterm birth: development and validation of a model to provide individualized risk assessment.
Celik E, To M, Gajewska K, Smith GC, Nicolaides KH.
Ultrasound Obstet Gynecol 2008;31:549-54. -
Prenatal diagnosis and outcome of echogenic fetal lung lesions.
Cavoretto P, Molina F, Poggi S, Davenport M, Nicolaides KH.
Ultrasound Obstet Gynecol 2008;32:769-83. -
Frontomaxillary facial angle in screening for trisomy 21 at 11 + 0 to 13 + 6 weeks.
Borenstein M, Persico N, Kagan KO, Gazzoni A, Nicolaides KH.
Ultrasound Obstet Gynecol 2008;32:5-11. -
Aberrant right subclavian artery at 11 + 0 to 13 + 6 weeks of gestation in chromosomally normal and abnormal fetuses.
Borenstein M, Cavoretto P, Allan L, Huggon I, Nicolaides KH.
Ultrasound Obstet Gynecol 2008;31:20-4. -
Maternal cardiac function in normotensive and pre-eclamptic intrauterine growth restriction.
Bamfo JE, Kametas NA, Chambers JB, Nicolaides KH.
Ultrasound Obstet Gynecol 2008;32:682-6. -
Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia.
Akolekar R, Zaragoza E, Poon LC, Pepes S, Nicolaides KH.
Ultrasound Obstet Gynecol 2008;32:732-9. -
Glycosaminoglycans and proteoglycans in the skin of aneuploid fetuses with increased nuchal translucency.
von Kaisenberg CS, Prols F, Nicolaides KH, Maass N, Meinhold-Heerlein I, Brand-Saberi B.
Hum Reprod 2003;18:2544-61. -
Ultrasound assessment of cervical length in threatened preterm labor.
Tsoi E, Akmal S, Rane S, Otigbah C, Nicolaides KH.
Ultrasound Obstet Gynecol 2003;21:552-5. -
Maternal weight correction of maternal serum PAPP-A and free beta-hCG MoM when screening for trisomy 21 in the first trimester of pregnancy.
Spencer K, Bindra R, Nicolaides KH.
Prenat Diagn 2003;23:851-5. -
Delta-NT or NT MoM: which is the most appropriate method for calculating accurate patient-specific risks for trisomy 21 in the first trimester?
Spencer K, Bindra R, Nix AB, Heath V, Nicolaides KH.
Ultrasound Obstet Gynecol 2003;22:142-8. -
Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years prospective experience.
Spencer K, Spencer CE, Power M, Dawson C, Nicolaides KH.
BJOG 2003;110:281-6.